Verastem Oncology to Participate in the B. Riley Securities 4th Annual Oncology Conference
11 Gennaio 2024 - 1:00PM
Business Wire
Verastem Oncology (Nasdaq: VSTM) (the “Company), a
biopharmaceutical company committed to advancing new medicines for
patients with cancer, today announced that the Company will
participate in a fireside chat at the B. Riley Securities 4th
Annual Oncology Conference on Thursday, January 18, 2024 at 4:00
p.m. ET.
To access the live webcast of the fireside chat, please contact
your B. Riley Securities sales representative.
Following the event, an archived replay of the fireside chat
will be available on the investors section of the Company’s website
at www.verastem.com.
About Verastem Oncology
Verastem Oncology (Nasdaq: VSTM) is a development-stage
biopharmaceutical company committed to the development and
commercialization of new medicines to improve the lives of patients
diagnosed with cancer. Our pipeline is focused on novel small
molecule drugs that inhibit critical signaling pathways in cancer
that promote cancer cell survival and tumor growth, including
RAF/MEK inhibition and focal adhesion kinase (FAK) inhibition. For
more information, please visit www.verastem.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240111104814/en/
Investors: Ryan Porter Argot Partners +1 212-600-1902
ryan.porter@argotpartners.com
Media: Lisa Buffington Corporate Communications +1
781-292-4502 lbuffington@verastem.com
Grafico Azioni Verastem (NASDAQ:VSTM)
Storico
Da Ago 2024 a Set 2024
Grafico Azioni Verastem (NASDAQ:VSTM)
Storico
Da Set 2023 a Set 2024